Roadshow
Light Sensing Biomarker Analyzer
Light Sensing Biomarker Analyzer backed by over 35 global patents revolutionizes early disease detection, particularly for neurodegenerative conditions like Alzheimer’s, by combining affordability, ease of use, and ultra-sensitivity. Priced at a quarter of existing products, it makes advanced diagnostics accessible to underserved populations, addressing the critical issue of late or missed diagnoses due to cost and complexity.
A major advantage of our product is its user-friendly design. Unlike other high-sensitivity diagnostic tools that require specialized training and are confined to centralized facilities, our solution is easy to use, allowing community healthcare providers to perform tests efficiently. This decentralization is crucial for extending access to diagnostic services in resource-limited settings.
Seeking Potential Strategic Partners:
-Genetic sequencing application partners
-Laboratories specializing in genetic sequencing services
-Biotechnology companies developing NGS panels/kits
-Distributors of genetic testing equipment and related services
-Pharmaceutical companies requiring precision medicine solutions for clinical trials
-Pharmaceutical and biotechnology companies with a high interest in precision medicine solution
Are you seeking innovative solutions to complex healthcare challenges? Visit us at MEDICA 2024 (Hall 16, Booth E02-3). We'll be demonstrating our cutting-edge technologies designed to improve patient outcomes and streamline healthcare processes.
#2024 MEDICA#TAIWAN PAVILION#TAIPEI
Light Sensing Biomarker Analyzer is an advanced blood test platform designed for early detection of neurodegenerative diseases, particularly Alzheimer’s. It leverages our patented Fiber Optic Particle Plasmon Resonance (FOPPR) technology and IN-Chip, an auto-flowing microfluidic chip, to detect protein biomarkers at concentrations up to 5 orders of magnitude lower than traditional methods, offering unmatched sensitivity and accuracy.
The platform is designed with portability and ease of use in mind, making it accessible for decentralized and resource-limited settings. The compact, user-friendly design allows healthcare providers to perform tests with minimal training, broadening the reach of advanced diagnostics. The IN-Chip technology streamlines fluid control without requiring pumps or complex tubing, ensuring a simple and reliable testing process.
The operating process is straightforward, requiring minimal sample preparation, which speeds up testing and makes it ideal for decentralized environments. The integration with cloud systems ensures secure storage, analysis, and sharing of results, supporting informed decision-making by healthcare providers.
In summary, our solution combines cutting-edge technology and streamlined operations to address the challenges of early neurodegenerative disease detection. By enabling early intervention, it not only improves patient outcomes but also reduces long-term healthcare costs, making it a valuable tool in managing diseases like Alzheimer’s.
- Company Instant NanoBiosensors Co., Ltd.
- Telephone 02-26538655
- Email cmo@instantnano.com
- Address RM.C328, 3rd FLOOR,NO99, LN. 130, SEC. 1, ACADEMIA RD., NANGANG DIST. TAIPEI, TAIWAN 115
Instant NanoBiosensors Co., Ltd. is an award-winning Taiwanese company specializing in the development of cutting-edge biosensor platforms and INvision embedded precision medicine solutions. Our mission is to continuously enhance biomedical research and diagnostic processes with simple, reliable, and affordable detection solutions.
With our unique and patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance), the Light-Sensing Biomarker Analyzer platforms provide instant and accurate results for a wide range of applications. By integrating novel biomarkers with advanced devices and biochips, we aim to revolutionize traditional immunoassays and diagnostic analyses, driving a more efficient healthcare ecosystem.
Since 2020, we have also leveraged our extensive experience and industry knowledge to establish the INVISION Genomics Business Unit. The INVISION Embedded Precision Medicine Solution revolutionizes clinical genomics by automating and streamlining processes from sample preparation to sequencing, data analysis, and report generation, simplifying procedures and saving time for healthcare providers. This enhances treatment accuracy and reduces delays. Additionally, its competitive pricing reduces the financial burden on patients, making high-quality precision medicine more accessible to all.